Pfizer-BioNTech’s coronavirus vaccine offers more protection than previously thought, with its effectiveness in preventing symptomatic disease reaching 97 percent according to real-world evidence published Thursday by the pharmaceutical companies.
Using data from January 17 to March 6 from Israel’s national vaccination campaign, Pfizer-BioNTech found that prevention against asymptomatic disease reached 94.
An earlier real-world study using data from between December 20, 2020, and February 1, 2021, had showed effectiveness at preventing symptomatic disease at 94 percent and asymptomatic illness at 92 percent.
Read more at Times of Israel.
{Matzav.com}
Wild. The ocean opens up and the wealth of a good dream finds a filtered creative expression. Wealth and liberty. The good of a town to run a wage of health.
All together. A win up.